Suppr超能文献

用于 CRISPR 的病毒递送系统。

Viral Delivery Systems for CRISPR.

机构信息

Edward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, NY 10032, USA.

Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Columbia University, New York, NY 10032, USA.

出版信息

Viruses. 2019 Jan 4;11(1):28. doi: 10.3390/v11010028.

Abstract

The frontiers of precision medicine have been revolutionized by the development of Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR)/Cas9 as an editing tool. CRISPR/Cas9 has been used to develop animal models, understand disease mechanisms, and validate treatment targets. In addition, it is regarded as an effective tool for genome surgery when combined with viral delivery vectors. In this article, we will explore the various viral mechanisms for delivering CRISPR/Cas9 into tissues and cells, as well as the benefits and drawbacks of each method. We will also review the history and recent development of CRISPR and viral vectors and discuss their applications as a powerful tool in furthering our exploration of disease mechanisms and therapies.

摘要

CRISPR/Cas9 的发展彻底改变了精准医学的前沿,它是一种编辑工具。CRISPR/Cas9 已被用于开发动物模型、了解疾病机制和验证治疗靶点。此外,当与病毒递送载体结合使用时,它被认为是一种有效的基因组手术工具。在本文中,我们将探讨将 CRISPR/Cas9 递送到组织和细胞中的各种病毒机制,以及每种方法的优缺点。我们还将回顾 CRISPR 和病毒载体的历史和最新发展,并讨论它们作为一种强大工具在进一步探索疾病机制和治疗方法中的应用。

相似文献

1
Viral Delivery Systems for CRISPR.
Viruses. 2019 Jan 4;11(1):28. doi: 10.3390/v11010028.
2
In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Bioconjug Chem. 2017 Apr 19;28(4):880-884. doi: 10.1021/acs.bioconjchem.7b00057. Epub 2017 Mar 17.
3
Delivery of CRISPR/Cas9 for therapeutic genome editing.
J Gene Med. 2019 Jul;21(7):e3107. doi: 10.1002/jgm.3107.
4
Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Drug Discov Today. 2018 Mar;23(3):519-533. doi: 10.1016/j.drudis.2018.01.014. Epub 2018 Jan 8.
5
Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field.
Sci China Life Sci. 2017 May;60(5):458-467. doi: 10.1007/s11427-017-9033-0. Epub 2017 May 2.
6
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Chem Rev. 2017 Aug 9;117(15):9874-9906. doi: 10.1021/acs.chemrev.6b00799. Epub 2017 Jun 22.
7
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
Drug Deliv Transl Res. 2023 May;13(5):1500-1519. doi: 10.1007/s13346-023-01320-z. Epub 2023 Mar 29.
8
Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Microb Cell Fact. 2017 Nov 16;16(1):205. doi: 10.1186/s12934-017-0815-5.
9
Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Methods Mol Biol. 2018;1715:113-133. doi: 10.1007/978-1-4939-7522-8_9.
10
Therapeutic and diagnostic relevance of Crispr technology.
Biomed Pharmacother. 2021 Jun;138:111487. doi: 10.1016/j.biopha.2021.111487. Epub 2021 Mar 25.

引用本文的文献

1
Viral and nonviral nanocarriers for CRISPR-based gene editing.
Nano Res. 2024 Oct;17(10):8904-8925. doi: 10.1007/s12274-024-6748-5. Epub 2024 Jun 20.
2
Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader.
Mol Ther Nucleic Acids. 2025 Jul 21;36(3):102640. doi: 10.1016/j.omtn.2025.102640. eCollection 2025 Sep 9.
5
CRISPR-Cas Systems: A Functional Perspective and Innovations.
Int J Mol Sci. 2025 Apr 12;26(8):3645. doi: 10.3390/ijms26083645.
6
Weaponizing CRISPR/Cas9 for selective elimination of cells with an aberrant genome.
DNA Repair (Amst). 2025 May;149:103840. doi: 10.1016/j.dnarep.2025.103840. Epub 2025 Apr 26.
7
Clinical perspective: Advancing hemophilia treatment through gene therapy approaches.
Mol Ther. 2025 Jun 4;33(6):2350-2362. doi: 10.1016/j.ymthe.2025.04.023. Epub 2025 Apr 21.
8
CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer's disease: progress and prospects.
Front Cell Neurosci. 2025 Apr 7;19:1578138. doi: 10.3389/fncel.2025.1578138. eCollection 2025.
9
Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects.
Expert Rev Mol Med. 2025 Mar 31;27:e16. doi: 10.1017/erm.2025.10.
10
Clinical development of therapeutic mRNA applications.
Mol Ther. 2025 Jun 4;33(6):2583-2609. doi: 10.1016/j.ymthe.2025.03.034. Epub 2025 Mar 25.

本文引用的文献

1
CRISPR/Cas9 genome surgery for retinal diseases.
Drug Discov Today Technol. 2018 Aug;28:23-32. doi: 10.1016/j.ddtec.2018.05.001. Epub 2018 Jun 18.
2
Direct observation of DNA target searching and cleavage by CRISPR-Cas12a.
Nat Commun. 2018 Jul 17;9(1):2777. doi: 10.1038/s41467-018-05245-x.
3
Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases.
Front Cell Dev Biol. 2018 May 23;6:46. doi: 10.3389/fcell.2018.00046. eCollection 2018.
4
Delivering CRISPR: a review of the challenges and approaches.
Drug Deliv. 2018 Nov;25(1):1234-1257. doi: 10.1080/10717544.2018.1474964.
5
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.
Science. 2018 Apr 27;360(6387):436-439. doi: 10.1126/science.aar6245. Epub 2018 Feb 15.
6
genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.
F1000Res. 2017 Dec 20;6:2153. doi: 10.12688/f1000research.11243.1. eCollection 2017.
7
Triple Vectors Expand AAV Transfer Capacity in the Retina.
Mol Ther. 2018 Feb 7;26(2):524-541. doi: 10.1016/j.ymthe.2017.11.019. Epub 2017 Dec 5.
8
Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes.
Yale J Biol Med. 2017 Dec 19;90(4):611-623. eCollection 2017 Dec.
10
CRISPR in Animals and Animal Models.
Prog Mol Biol Transl Sci. 2017;152:95-114. doi: 10.1016/bs.pmbts.2017.07.010. Epub 2017 Sep 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验